Analytical reagents designed for the study of growth hormone secretagogues and physiological optimization. These analogs, including CJC-1295 (No DAC) and Ipamorelin, are curated for researchers investigating the somatotropic axis and pulsatile release patterns. Our Performance & Endurance series offers the precise chemical markers required for high-level bio-optimization research within Canada.
Performance & Endurance
Performance & Endurance
The study of the somatotropic axis involves investigating the complex feedback loops between the hypothalamus and the anterior pituitary gland. Our Performance & Endurance series features high-purity Growth Hormone Secretagogues (GHS) designed to observe the stimulation of endogenous growth hormone production through specific receptor pathways.
Ipamorelin is a selective GHSR (Ghrelin Receptor) agonist researched for its ability to mimic the hunger hormone ghrelin. In a laboratory setting, Ipamorelin is distinguished by its high selectivity; unlike earlier GHRP analogs, it demonstrates a minimal effect on cortisol, prolactin, and ACTH levels. This makes it a primary reference compound for investigating pulsatile GH release and its subsequent effects on nitrogen retention, lean tissue preservation, and lipolysis without the interference of systemic stress hormones.
CJC-1295 (Modified GRF 1-29) is a synthetic analog of Growth Hormone Releasing Hormone (GHRH). By modifying the first 29 amino acids of the GHRH sequence, researchers have created a compound with a shorter half-life that allows for the observation of natural, pulsatile GH rhythms. This "No DAC" version is preferred in research protocols where mimicking the body's natural physiological spikes is a requirement. Analysis of this peptide focuses on its ability to increase IGF-1 (Insulin-like Growth Factor 1) levels through sustained pituitary stimulation.
A significant area of study involves the synergistic application of a GHRH (CJC-1295 No DAC) and a GHRP (Ipamorelin). Researchers observe the "double signal" effect: the GHRH increases the quantity of GH-secreting cells participating in a pulse, while the GHRP triggers the timing of the pulse itself. This combination is researched to understand maximal peak GH amplitude and its role in enhancing endurance markers, connective tissue density, and metabolic efficiency. Maintaining lyophilized stability is critical, as these peptide chains are highly sensitive to amino acid cleavage if exposed to improper storage temperatures.